definiens: shall mean, collectively, ( a ) all patent rights, know -how -2- or other intellectual property rights or technology of ABX in or to ( i ) all antigens other than the Antigen, including without limitation ( A ) compositions of such antigens or of Gen etic Materials that encode such antigens ; ( B ) uses of such antigens ; ( C ) antibodies or other compositions that bind to such antigens, Genetic Materials that encode such antibodies or compositions, and Antibody Cells that express, secrete, or contain such antibodies, Genetic Materials or compositions ; and ( D ) uses of such antibodies, Genetic Materials or compositions ; ( ii ) methods to discover novel antigens ; and ( iii ) methods of using antigens other than to create antibodies ; ( b)(i ) all patent applications h eretofore or hereafter filed in any country which claim ABX Materials ( except for those described in clause ( a ) of Section 1.4 of the Research License and Option Agreement ) or ABX Inventions ; ( ii ) all patents that have issued or in the future issue from any of the foregoing patent applications, including without limitation utility, model and design patents and certificates of invention ; and ( iii ) all divisionals, continuations, continuations -in - part, reissues, renewals, extensions or additions to any such patents and patent applications ; and ( c ) inventions, discoveries, data, information, methods, techniques, technology and other results, whether or not patentable but which are not generally known, regarding ABX Materials ( except for those described in clau se ( a ) of Section 1.4 of the Research License and Option Agreement ) and ABX Inventions